GT Biopharma Inc (GTBP)

[animaljive]

WHEREAS, each of William Heavener (“Heavener”), Red Mango Ltd. (“Red Mango”), Kasower (the forgoing individuals and entities, collectively, the “October 2014 Investors”) and the Company are party to that certain Securities Purchase Agreement dated October 14, 2014, as amended from time to time (the “October 2014 Purchase Agreement”), pursuant to which the Company issued 10% Convertible Debentures (the “October 2014 Debentures”);

WHEREAS, each of Theorem, Korompis, Raymond Pribadi, Bristol, Kasower, Alpha, Heavener, Red Mango, Scott Williams, Barry Wolfe (the forgoing individuals and entities, collectively, the “March 2015 Investors”) and the Company are party to that certain Securities Purchase Agreement dated March 12, 2015, as amended from time to time (the “March 2015 Purchase Agreement”), pursuant to which the Company issued 10% Convertible Debentures (the “March 2015 Debentures”);